Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?
OBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccination in peritoneal dialysis patients are scarce. The current study was conducted on a group of peritoneal dialysis patients to learn how the response to hepatitis B virus vaccination varies according...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculdade de Medicina / USP
2011-01-01
|
Series: | Clinics |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000900009 |
id |
doaj-4ad448dfc7d04bd58e1903bdff23f3c0 |
---|---|
record_format |
Article |
spelling |
doaj-4ad448dfc7d04bd58e1903bdff23f3c02020-11-25T00:56:06ZengFaculdade de Medicina / USPClinics1807-59321980-53222011-01-016691559156210.1590/S1807-59322011000900009Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter?Erkan DervisogluMelih SimsekAhmet YilmazOBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccination in peritoneal dialysis patients are scarce. The current study was conducted on a group of peritoneal dialysis patients to learn how the response to hepatitis B virus vaccination varies according to the patient's clearance of urea normalized to total body water (Kt/V). METHODS: A convenience sample of 33 peritoneal dialysis patients (13 women and 20 men, with a mean age of 49¡12 years) was administered double doses (20 μg IM in each deltoid muscle) of recombinant hepatitis B vaccine at 0, 1, 2, and 6 months. Response to immunization was measured at one to three months after the final dose of vaccine. The subjects were divided into groups according to the level of antibodies to hepatitis B surface antigen (anti-HBs), including non-responders ( < 10 IU/L), weak responders (10-100 IU/L), and good responders ( > 100 IU/L). RESULTS: Among non-responders, weak responders, and good responders, significant differences were found in age (54 ± 12 vs. 56 ± 9 vs. 45¡12 years, respectively; p = 0.049) and recombinant human erythropoietin use (20 vs. 29 vs. 76%, respectively; p = 0.016). No significant differences in weekly total Kt/V (p = 0.704), weekly peritoneal Kt/V (p = 0.064) and residual glomerular filtration rate (p = 0.355) were found across the three groups. CONCLUSIONS: Delivered clearance measured by weekly peritoneal Kt/V and total clearance measured by weekly total Kt/V did not predict the response to hepatitis B virus vaccination in patients on peritoneal dialysis.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000900009Continuous ambulatory peritoneal dialysisHepatitis B virusVaccinationDialysis adequacyKt/V |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Erkan Dervisoglu Melih Simsek Ahmet Yilmaz |
spellingShingle |
Erkan Dervisoglu Melih Simsek Ahmet Yilmaz Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter? Clinics Continuous ambulatory peritoneal dialysis Hepatitis B virus Vaccination Dialysis adequacy Kt/V |
author_facet |
Erkan Dervisoglu Melih Simsek Ahmet Yilmaz |
author_sort |
Erkan Dervisoglu |
title |
Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter? |
title_short |
Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter? |
title_full |
Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter? |
title_fullStr |
Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter? |
title_full_unstemmed |
Antibody response following Hepatitis B vaccination in peritoneal dialysis patients: does normalized urea clearance matter? |
title_sort |
antibody response following hepatitis b vaccination in peritoneal dialysis patients: does normalized urea clearance matter? |
publisher |
Faculdade de Medicina / USP |
series |
Clinics |
issn |
1807-5932 1980-5322 |
publishDate |
2011-01-01 |
description |
OBJECTIVES: Data on the factors that contribute to the antibody response to hepatitis B virus vaccination in peritoneal dialysis patients are scarce. The current study was conducted on a group of peritoneal dialysis patients to learn how the response to hepatitis B virus vaccination varies according to the patient's clearance of urea normalized to total body water (Kt/V). METHODS: A convenience sample of 33 peritoneal dialysis patients (13 women and 20 men, with a mean age of 49¡12 years) was administered double doses (20 μg IM in each deltoid muscle) of recombinant hepatitis B vaccine at 0, 1, 2, and 6 months. Response to immunization was measured at one to three months after the final dose of vaccine. The subjects were divided into groups according to the level of antibodies to hepatitis B surface antigen (anti-HBs), including non-responders ( < 10 IU/L), weak responders (10-100 IU/L), and good responders ( > 100 IU/L). RESULTS: Among non-responders, weak responders, and good responders, significant differences were found in age (54 ± 12 vs. 56 ± 9 vs. 45¡12 years, respectively; p = 0.049) and recombinant human erythropoietin use (20 vs. 29 vs. 76%, respectively; p = 0.016). No significant differences in weekly total Kt/V (p = 0.704), weekly peritoneal Kt/V (p = 0.064) and residual glomerular filtration rate (p = 0.355) were found across the three groups. CONCLUSIONS: Delivered clearance measured by weekly peritoneal Kt/V and total clearance measured by weekly total Kt/V did not predict the response to hepatitis B virus vaccination in patients on peritoneal dialysis. |
topic |
Continuous ambulatory peritoneal dialysis Hepatitis B virus Vaccination Dialysis adequacy Kt/V |
url |
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000900009 |
work_keys_str_mv |
AT erkandervisoglu antibodyresponsefollowinghepatitisbvaccinationinperitonealdialysispatientsdoesnormalizedureaclearancematter AT melihsimsek antibodyresponsefollowinghepatitisbvaccinationinperitonealdialysispatientsdoesnormalizedureaclearancematter AT ahmetyilmaz antibodyresponsefollowinghepatitisbvaccinationinperitonealdialysispatientsdoesnormalizedureaclearancematter |
_version_ |
1725228255691145216 |